Patent · US Active

BACE1 inhibitors

US10399969B2 · kind B2 · utility

2Cited by

1References

2Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Bjoern Bartels · Schopfheim, DE
Cosimo Dolente · Allschwil, CH
Wolfgang Guba · Memmingen, DE
Wolfgang Haap · Bad Kötzting, DE
Ulrike Obst Sander · Sursee, CH
Jens-Uwe Peters · Weil am Rhein, DE
Thomas Woltering · Freiburg (Elbe), DE

Key dates

Filing date	Jul 12, 2018
Grant date	Sep 3, 2019
Priority date	—
Expiry date	Jul 12, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides a compound of formula I, having BACE1 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and/or prophylactic treatment of e.g. Alzheimer's disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.